Invesco Biotechnology & Genome ETF
PBE
Closed
$97.59
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
PBE was created on 2005-06-23 by Invesco. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 373.12m in AUM and 32 holdings. PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.
Company
Invesco
Asset class
Equity
Inception date
2005
Investment segment
Health Care
ISIN
US46137V7872
Website
Key stats
Open
$97.12
Volume
11.06K
AUM
$392.36M
Prev. close
$96.56
Expense ratio
0.58%
P/E
23.15
$97.10
Day’s Range
$97.79
$75.50
52W Range
$98.32
What’s in the fund
2
Total sectors
Health Care
99.94%
Others
0.06%
Returns
Performance
_
Difference
_
Invesco Biotechnology & Genome ETF
Jun
26
Dividends
The last payment date was Jun 26, 2026
Div. per Share
$0.81
Div. Yield
0.84%
Div. Growth YoY
883.27%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply